- Home
- SGA vs INCR Comparison
SGA vs INCR Comparison
Compare SGA & INCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SGA
- INCR
- Stock Information
- Founded
- SGA 1986
- INCR 1994
- Country
- SGA United States
- INCR Israel
- Employees
- SGA N/A
- INCR N/A
- Industry
- SGA Broadcasting
- INCR Biotechnology: Pharmaceutical Preparations
- Sector
- SGA Consumer Discretionary
- INCR Health Care
- Exchange
- SGA Nasdaq
- INCR Nasdaq
- Market Cap
- SGA 89.2M
- INCR 80.1M
- IPO Year
- SGA 1992
- INCR N/A
- Fundamental
- Price
- SGA $12.62
- INCR $1.32
- Analyst Decision
- SGA
- INCR
- Analyst Count
- SGA 0
- INCR 0
- Target Price
- SGA N/A
- INCR N/A
- AVG Volume (30 Days)
- SGA 16.0K
- INCR 54.3K
- Earning Date
- SGA 11-07-2024
- INCR 12-03-2024
- Dividend Yield
- SGA 8.02%
- INCR N/A
- EPS Growth
- SGA N/A
- INCR N/A
- EPS
- SGA 0.75
- INCR N/A
- Revenue
- SGA $110,669,000.00
- INCR $72,420,918.00
- Revenue This Year
- SGA $0.49
- INCR N/A
- Revenue Next Year
- SGA $0.18
- INCR $39.30
- P/E Ratio
- SGA $16.82
- INCR N/A
- Revenue Growth
- SGA N/A
- INCR N/A
- 52 Week Low
- SGA $11.71
- INCR $1.12
- 52 Week High
- SGA $27.00
- INCR $3.72
- Technical
- Relative Strength Index (RSI)
- SGA 39.51
- INCR 35.86
- Support Level
- SGA $11.71
- INCR $1.17
- Resistance Level
- SGA $14.09
- INCR $1.54
- Average True Range (ATR)
- SGA 0.41
- INCR 0.10
- MACD
- SGA -0.08
- INCR -0.01
- Stochastic Oscillator
- SGA 38.24
- INCR 24.59
About SGA Saga Communications Inc. (FL)
Saga Communications Inc is a broadcast company engaged in acquiring, developing, and operating broadcast properties. The company's objective is to operate top billing radio stations in mid-sized markets and It derives a majority of its revenue from the sale of advertising for broadcast on its stations.
About INCR Intercure Ltd.
Intercure Ltd is engaged in the research, cultivation, production, and distribution of pharma-grade cannabis-based products. The products are distributed to hospitals, pharmacies, research, and government organizations. The company has two segments namely: Cannabis segment and Biomed segment, out of which it derives maximum revenue from Cannabis segment.